Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

103.75
Delayed Data
As of Jul 31
 +0.57 / +0.55%
Today’s Change
84.17
Today|||52-Week Range
106.84
+11.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$245.8B

Company Description

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment provides generic pharmaceuticals. The Vaccines and Diagnostics segment provides human vaccines and blood testing diagnostics. The Consumer Health segment contains two divisions, OTC and Animal Health. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Contact Information

Novartis AG
Lichtstrasse 35
Basel Basel-stadt (basle Town) 4056
P:(161) 324-1111
Investor Relations:
(161) 324-7944

Employees

Shareholders

Other institutional4.82%
Mutual fund holders3.95%
Individual stakeholders--

Top Executives

Joseph JimenezChief Executive Officer
Harry KirschChief Financial Officer
Eric CornutChief Ethics, Compliance & Policy Officer
Jürgen Brokatzky-GeigerGlobal Head-Corporate Responsibility
Gina Massa MiasPrincipal